Corpus ID: 43924886

DEPRESSION : Mind and Body Advances in the Understanding and Treatment of Depression and its Physical Symptoms Biological and Psychosocial Correlates of Perimenopausal Depression : Implications for Treatment

  title={DEPRESSION : Mind and Body Advances in the Understanding and Treatment of Depression and its Physical Symptoms Biological and Psychosocial Correlates of Perimenopausal Depression : Implications for Treatment},
  author={Alan F. Schatzberg and Maurizio Fava and John F. Greden and Yves Lecrubier and Natalie Rasgon and Madhukar H. Trivedi and Po W Wang},

Figures from this paper


Pharmacologic treatment of depression in patients with heart disease.
Although the data are limited and are primarily from open or comparator trials, the tricyclics and selective serotonin reuptake inhibitors (SSRI) are effective for treatment of depression in patients with ischemic heart disease (IHD), and response rates are comparable with those reported in depressed patients without heart disease. Expand
Phobic Anxiety and Risk of Coronary Heart Disease and Sudden Cardiac Death Among Women
High levels of phobic anxiety are associated with an increased risk of fatal CHD, particularly from SCD, and some but not all of this risk can be accounted for by CHD risk factors associated with phobic Anxiety. Expand
Anxiety, depression, and prognosis after myocardial infarction: is there a causal association?
It is commonly thought that traditional risk factors, namely, hypertension, high cholesterol, cigarette smoking, and physical inactivity, can at best explain only 50% of the variation in mortality inExpand
Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review.
This quantitative review suggests that depressive symptoms contribute a significant independent risk for the onset of coronary disease, a risk that is greater than the risk conferred by passive smoking but less than therisk conferred by active smoking. Expand
Mental disorders and cause-specific mortality
Schizophrenia and depression are associated with an elevated risk of natural and unnatural deaths in Finns. Expand
Neurotrophins and depression.
  • C. Altar
  • Psychology, Medicine
  • Trends in pharmacological sciences
  • 1999
Existing treatments of depression might work by increasing endogenous brain levels of BDNF or NT-3, which in turn could promote monoamine-containing neurone growth and function, and drugs that selectively stimulate the production of neurotrophins could represent a new generation of antidepressants. Expand
Exercise intensity and longevity in men.
Vigorous, but not nonvigorously, physical activities were associated with longevity and different criteria were used to categorize the energy expenditure in specific analytical approaches. Expand
Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments
The enhanced induction and prolonged expression of BDNF in response to chronic ECS and antidepressant drug treatments could promote neuronal survival, and protect neurons from the damaging effects of stress. Expand
A Concurrent Validation Study of the NCHS General Well-Being Schedule. Vital and Health Statistics (Series 2, No
  • DHEW Publication No. HRA 78-1347) Hyattsville, MD: National Center for Health Statistics,
  • 1977
Depression, indirect clinical markers of cardiac disease severity, and mortality following myocardial infarction
Where associations between depression following MI and mortality appear, they could reflect the confounding of depression with disease severity and it is argued that it depends on the accuracy of patients’ perceptions about the severity of their condition. Expand